Number sleven, The same type of study showed that high blood EPA levels was inversely related to strokes and heart attacks. How long will it take for some retrospective study to show the same with Alzheimer's disease?
What an amazing and beneficial drug Vascepa is, yet people like Nissen rally against it at every turn? Why no interest in Vascepa in AD besides one small VA study? Why aren't there foreign studies in Europe or China?
Why does BIIB get their expensive and impotent drug approved for AD, and a relatively inexpensive drug (Vascepa) with excellent potential get ignored?
Market Data 
Markets 
AI
